REFERENCES
- Wolff J A, Malone R W, Williams P, et al, Direct gene transfer into mouse muscle in vivo. Science. 1990; 247: 1465–8. [PUBMED], [INFOTRIEVE]
- Tang D C, De, Vit M, Johnston S A.. Genetic immunization is a simple method for eliciting an immune response. Nature. 1992; 356: 152–4. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cox G J, Zamb T J, Babiuk L A.. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 1993; 67: 5664–7. [PUBMED], [INFOTRIEVE]
- Krieg A M.. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20: 709–60. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Donnelly J J, Ulmer J B, Shiver J W, et al, DNA vaccines. Annu Rev Immunol. 1997; 15: 617–48. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Van Drunen Littel-van, den Hurk S, Braun R P, Lewis P J, et al, Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunol. 1999; 12: 67–77. [PUBMED], [INFOTRIEVE]
- Lewis P J, van Drunen Littel-Van, Den H, Babiuk L A.. Induction of immune responses to bovine herpesvirus type 1 gD in passively immune mice after immunization with a DNA-based vaccine. J Gen Virol. 1999; 80: 2829–37. [PUBMED], [INFOTRIEVE]
- Liu M A, McClements W, Ulmer J B, et al, Immunization of non-human primates with DNA vaccines. Vaccine. 1997; 15: 909–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lechardeur D, Lukacs G L.. Intracellular barriers to non-viral gene transfer. Curr Gene Ther. 2002; 2: 183–94. [PUBMED], [INFOTRIEVE]
- Wattiaux R, Laurent N, Wattiaux-De Coninck S, et al, Endosomes, lysosomes: their implication in gene transfer. Adv Drug Deliv Rev. 2000; 41: 201–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Johnston S, Talaat A, McGuire M.. Genetic Immunization. What's in a Name?. Arch Med Res. 2002; 33: 325, [CROSSREF], [PUBMED], [INFOTRIEVE]
- van Drunen Littel-van, den Hurk S, Gerdts V, Loehr B I, et al, Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv Drug Deliv Rev. 2000; 43: 13–28. [PUBMED], [INFOTRIEVE]
- Dupuis M, Denis-Mize K, Woo C, et al, Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol. 2000; 165: 2850–8. [PUBMED], [INFOTRIEVE]
- Kerr I M, Stark G R.. The antiviral effects of the interferons and their inhibition. J Interferon Res. 1992; 12: 237–40. [PUBMED], [INFOTRIEVE]
- Harms J S, Oliveira S C, Splitter G A.. Regulation of transgene expression in genetic immunization. Braz J Med Biol Res. 1999; 32: 155–62. [PUBMED], [INFOTRIEVE]
- Lee A H, Suh Y S, Sung J H, et al, Comparison of various expression plasmids for the induction of immune response by DNA immunization. Mol Cells. 1997; 7: 495–501. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nettelbeck D M, Jerome V, Muller R.. Gene therapy: designer promoters for tumour targeting. Trends Genet. 2000; 16: 174–81. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gebhard J R, Zhu J, Cao X, et al, DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes. Vaccine. 2000; 18: 1837–46. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bojak A, Hammer D, Wolf H, et al, Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis. Vaccine. 2002; 20: 1975–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Loirat D, Li Z, Mancini M, et al, Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology. 1999; 260: 74–83. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Weeratna R D, Wu T, Efler S M, et al, Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters. Gene Ther. 2001; 8: 1872–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Tornoe J, Kusk P, Johansen T, et al, Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites. Gene. 2002; 297: 21, [CROSSREF], [PUBMED], [INFOTRIEVE]
- Saier M H, Jr.. Differential codon usage: a safeguard against inappropriate expression of specialized genes?. FEBS Lett. 1995; 362: 1–4. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kurland C G.. Codon bias and gene expression. FEBS Lett. 1991; 285: 165–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Andersson S G, Kurland C G.. Codon preferences in free-living microorganisms. Microbiol Rev. 1990; 54: 198–210. [PUBMED], [INFOTRIEVE]
- Holm L.. Codon usage and gene expression. Nucleic Acids Res. 1986; 14: 3075–87. [PUBMED], [INFOTRIEVE]
- Stratford R, Douce G, Zhang-Barber L, et al, Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine. 2000; 19: 810–5. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Liu W J, Zhao K N, Gao F G, et al, Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine. 2001; 20: 862–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Liu W J, Gao F, Zhao K N, et al, Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology. 2002; 301: 43–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Deml L, Bojak A, Steck S, et al, Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol. 2001; 75: 10991–1001. [CROSSREF], [PUBMED], [INFOTRIEVE]
- zur Megede J, Chen M C, Doe B, et al, Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J Virol. 2000; 74: 2628–35. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Vinner L, Nielsen H V, Bryder K, et al, Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons. Vaccine. 1999; 17: 2166–75. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Narum D L, Kumar S, Rogers W O, et al, Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun. 2001; 69: 7250–3. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nagata T, Uchijima M, Yoshida A, et al, Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem Biophys Res Commun. 1999; 261: 445–51. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Uchijima M, Yoshida A, Nagata T, et al, Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol. 1998; 161: 5594–9. [PUBMED], [INFOTRIEVE]
- Karlin S, Mrazek J, Campbell A M.. Codon usages in different gene classes of the Escherichia coli genome. Mol Microbiol. 1998; 29: 1341–55. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Jenkins G M, Pagel M, Gould E A, et al, Evolution of base composition and codon usage bias in the genus Flavivirus. J Mol Evol. 2001; 52: 383–90. [PUBMED], [INFOTRIEVE]
- Wu L F, Saier M H, Jr.. Differences in codon usage among genes encoding proteins of different function in Rhodobacter capsulatus. Res Microbiol. 1991; 142: 943–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kwissa M, Unsinger J, Schirmbeck R, et al, Polyvalent DNA vaccines with bidirectional promoters. J Mol Med. 2000; 78: 495–506. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kamiya H, Yamazaki J, Harashima H.. Size and topology of exogenous DNA as determinant factors of transgene transcription in mammalian cells. Gene Ther. 2002; 9: 1500–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mizuguchi H, Xu Z, Ishii-Watabe A, et al, IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000; 1: 376–82. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Wild J, Gruner B, Metzger K, et al, Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine. 1998; 16: 353–60. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Manoj S, Babiuk L A, van Drunen Littel-van, den Hurk S.. Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino terminal subunit of glycoprotein B results in reduced gB-specific immune responses. Virology, in press.
- O'Hagan D, Singh M, Ugozzoli M, et al, Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J Virol. 2001; 75: 9037–43. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Jin J, Yang J Y, Liu J, et al, DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV. World J Gastroenterol. 2002; 8: 505–10. [PUBMED], [INFOTRIEVE]
- Gerloni M, Xiong S, Mukerjee S, et al, Functional cooperation between T helper cell determinants. Proc Natl Acad Sci USA. 2000; 97: 13269–74. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Patten P A, Howard R J, Stemmer W P.. Applications of DNA shuffling to pharmaceuticals and vaccines. Curr Opin Biotechnol. 1997; 8: 724–33. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Osen W, Peiler T, Ohlschlager P, et al, A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity. Vaccine. 2001; 19: 4276–86. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Braun R, Babiuk L A, van Drunen Littel-van, den H.. Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation. J Gen Virol. 1998; 79: 2965–70. [PUBMED], [INFOTRIEVE]
- Collings A, Pitkanen J, Strengell M, et al, Humoral and cellular immune responses to HIV-1 nef in mice DNA-immunized with non-replicating or self-replicating expression vectors. Vaccine. 1999; 18: 460–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Herrera A M, Rodriguez E G, Hernandez T, et al, A family of compact plasmid vectors for DNA immunization in humans. Biochem Biophys Res Commun. 2000; 279: 548–51. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Sato Y, Roman M, Tighe H, et al, Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 1996; 273: 352–4. [PUBMED], [INFOTRIEVE]
- Pontarollo R A, Babiuk L A, Hecker R, et al, Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol. 2002; 83: 2973–81. [PUBMED], [INFOTRIEVE]
- Panayotatos N.. Recombinant protein production with minimal-antibiotic-resistance vectors. Gene. 1988; 74: 357–63. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Williams S G, Cranenburgh R M, Weiss A M, et al, Repressor titration: a novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Res. 1998; 26: 2120–4. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cranenburgh R M, Hanak J A, Williams S G, et al, Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res. 2001; 29: E26, [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schakowski F, Gorschluter M, Junghans C, et al, A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol Ther. 2001; 3: 793–800. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Zhang E P, Muller A, Schulte F, et al, Minimizing side effects of ballistic gene transfer into the murine corneal epithelium. Graefes Arch Clin Exp Ophthalmol. 2002; 240: 114–9. [PUBMED], [INFOTRIEVE]
- Boretti F S, Leutenegger C M, Mislin C, et al, Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS. 2000; 14: 1749–57. [PUBMED], [INFOTRIEVE]
- Leutenegger C M, Boretti F S, Mislin C N, et al, Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol. 2000; 74: 10447–57. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Muller A, Zhang E P, Schroff M, et al, Influence of ballistic gene transfer on antigen-presenting cells in murine corneas. Graefes Arch Clin Exp Ophthalmol. 2002; 240: 851–9. [PUBMED], [INFOTRIEVE]
- Konig Merediz S A, Zhang E P, Wittig B, et al, Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation. Graefes Arch Clin Exp Ophthalmol. 2000; 238: 701–7. [PUBMED], [INFOTRIEVE]
- Schirmbeck R, Konig-Merediz S A, Riedl P, et al, Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide. J Mol Med. 2001; 79: 343–50. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Medzhitov R, Janeway C A, Jr.. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997; 91: 295–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Armant M A, Fenton M J.. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol. 2002; 3, REVIEWS3011.
- Hemmi H, Takeuchi O, Kawai T, et al, A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408: 740–5. [PUBMED], [INFOTRIEVE]
- Bauer S, Kirschning C J, Hacker H, et al, Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA. 2001; 98: 9237–42. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Chu R S, Targoni O S, Krieg A M, et al, CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 1997; 186: 1623–31. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lipford G B, Bauer M, Blank C, et al, CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol. 1997; 27: 2340–4. [PUBMED], [INFOTRIEVE]
- Carson D A, Raz E.. Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J Exp Med. 1997; 186: 1621–2. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Weiss R, Scheiblhofer S, Freund J, et al, Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine. 2002; 20: 3148, [CROSSREF], [PUBMED], [INFOTRIEVE]
- Jackson L A, Austin G, Chen R T, et al, Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine. 2001; 19: 4703–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Marshall J L, Hoyer R J, Toomey M A, et al, Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J Clin Oncol. 2000; 18: 3964–73. [PUBMED], [INFOTRIEVE]
- Williams J, Fox-Leyva L, Christensen C, et al, Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine. 2000; 18: 1939–43. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Conry R M, Khazaeli M B, Saleh M N, et al, Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration. Clin Cancer Res. 1999; 5: 2330–7. [PUBMED], [INFOTRIEVE]
- Chen D, Zuleger C, Chu Q, et al, Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses. AIDS Res Hum Retroviruses. 2002; 18: 715–22. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Chen D, Periwal S B, Larrivee K, et al, Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J Virol. 2001; 75: 7956–65. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Chen D, Endres R L, Erickson C A, et al, Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat Med. 2000; 6: 1187–90. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rogers W O, Baird J K, Kumar A, et al, Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect Immun. 2001; 69: 5565–72. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Manam S, Ledwith B J, Barnum A B, et al, Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology. 2000; 43: 273–81. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gramzinski R A, Millan C L, Obaldia N, et al, Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol Med. 1998; 4: 109–18. [PUBMED], [INFOTRIEVE]
- Degano P, Sarphie D F, Bangham C R.. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. Vaccine. 1998; 16: 394–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Zucchelli S, Capone S, Fattori E, et al, Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol. 2000; 74: 11598–607. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Braun R P, Babiuk L A, Loehr B I, et al, Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology. 1999; 265: 46–56. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Jankovic D, Liu Z, Gause W C.. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 2001; 22: 450–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mir L M.. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry. 2001; 53: 1–10. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mathiesen I.. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 1999; 6: 508–14. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Widera G, Austin M, Rabussay D, et al, Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol. 2000; 164: 4635–40. [PUBMED], [INFOTRIEVE]
- Selby M, Goldbeck C, Pertile T, et al, Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol. 2000; 83: 147–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Drabick J J, Glasspool-Malone J, King A, et al, Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther. 2001; 3: 249–55. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Glasspool-Malone J, Somiari S, Drabick J J, et al, Efficient nonviral cutaneous transfection. Mol Ther. 2000; 2: 140–6. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Babiuk S, Baca-Estrada M, Foldvari M, et al, Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine. 2002; 20: 3399, [CROSSREF], [PUBMED], [INFOTRIEVE]
- Glasspool-Malone J, Steenland P R, McDonald R J, et al, DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor. J Gene Med. 2002; 4: 323–32. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Glasspool-Malone J, Malone R W.. Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields. Methods Enzymol. 2002; 346: 72–91. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Shi Z, Curiel D T, Tang D C.. DNA-based non-invasive vaccination onto the skin. Vaccine. 1999; 17: 2136–41. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Liu L J, Watabe S, Yang J, et al, Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses. Vaccine. 2001; 20: 42–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Watabe S, Xin K Q, Ihata A, et al, Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine. 2001; 19: 4434–44. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Fan H, Lin Q, Morrissey G R, et al, Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol. 1999; 17: 870–2. [PUBMED], [INFOTRIEVE]
- Inoue T, Inoue Y, Hayashi K, et al, Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis. Cornea. 2002; 21: 106–10. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Loehr B I, Willson P, Babiuk L A, et al, Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J Virol. 2000; 74: 6077–86. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Stevceva L, Abimiku A G, Franchini G.. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses. Genes Immun. 2000; 1: 308–15. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gallichan W S, Rosenthal K L.. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med. 1996; 184: 1879–90. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Eo S K, Gierynska M, Kamar A A, et al, Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. J Immunol. 2001; 166: 5473–9. [PUBMED], [INFOTRIEVE]
- McCluskie M J, Weeratna R D, Payette P J, et al, Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol Med Microbiol. 2002; 32: 179–85. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Etchart N, Buckland R, Liu M A, et al, Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J Gen Virol. 1997; 78: 1577–80. [PUBMED], [INFOTRIEVE]
- Etchart N, Desmoulins P O, Chemin K, et al, Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein. J Immunol. 2001; 167: 384–91. [PUBMED], [INFOTRIEVE]
- Desvignes C, Etchart N, Kehren J, et al, Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J Immunol. 2000; 164: 2515–22. [PUBMED], [INFOTRIEVE]
- Eriksson K, Ahlfors E, George-Chandy A, et al, Antigen presentation in the murine oral epithelium. Immunology. 1996; 88: 147–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- McCluskie M J, Brazolot Millan C L, Gramzinski R A, et al, Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med. 1999; 5: 287–300. [PUBMED], [INFOTRIEVE]
- Sigel M B, Sinha Y N, VanderLaan W P.. Production of antibodies by inoculation into lymph nodes. Methods Enzymol. 1983; 93: 3–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Maloy K J, Erdmann I, Basch V, et al, Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci USA. 2001; 98: 3299–303. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gretz J E, Norbury C C, Anderson A O, et al, Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits, while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med. 2000; 192: 1425–40. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gregoriadis G, Bacon A, Caparros-Wanderley W, et al, A role for liposomes in genetic vaccination. Vaccine. 2002; 20(Suppl 5)B1–9. [PUBMED], [INFOTRIEVE]
- Jones D H, Corris S, Mc Donald S, et al, Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 1997; 15: 814–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Briones M, Singh M, Ugozzoli M, et al, The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery. Pharm Res. 2001; 18: 709–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Denis-Mize K S, Dupuis M, MacKichan M L, et al, Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther. 2000; 7: 2105–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cui Z, Mumper R J.. Genetic immunization using nanoparticles engineered from microemulsion precursors. Pharm Res. 2002; 19: 939–46. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cui Z, Mumper R J.. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. Int J Pharm. 2002; 238: 229–39. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cui Z, Mumper R J.. Topical immunization using nanoengineered genetic vaccines. J Control Release. 2002; 81: 173–84. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cui Z, Mumper R J.. Chitosan-based nanoparticles for topical genetic immunization. J Control Release. 2001; 75: 409–19. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lim Y B, Kim S M, Suh H, et al, Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug Chem. 2002; 13: 952–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mittal S K, Aggarwal N, Sailaja G, et al, Immunization with DNA, adenovirus, or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. Vaccine. 2000; 19: 253–63. [PUBMED], [INFOTRIEVE]
- Mutwiri G, Bowersock T, Kidane A, et al, Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres. Vet Immunol Immunopathol. 2002; 87: 269–76. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Graff A, Sauer M, Van, Gelder P, et al, Virus-assisted loading of polymer nanocontainer. Proc Natl Acad Sci USA. 2002; 99: 5064–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ross G F, Bruno M D, Uyeda M, et al, Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitor. Gene Ther. 1998; 5: 1244–50. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hallick R B, Chelm B K, Gray P W, et al, Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation. Nucleic Acids Res. 1977; 4: 3055–64. [PUBMED], [INFOTRIEVE]
- Lopez-Fuertes L, Perez-Jimenez E, Vila-Coro A J, et al, DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine. 2002; 21: 247–57. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Finlay B B, Cossart P.. Exploitation of mammalian host cell functions by bacterial pathogens. Science. 1997; 276: 718–25. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Paglia P, Medina E, Arioli I, et al, Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood. 1998; 92: 3172–6. [PUBMED], [INFOTRIEVE]
- Kaufmann S H.. Immunity to intracellular bacteria. Annu Rev Immunol. 1993; 11: 129–63. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gentschev I, Mollenkopf H, Sokolovic Z, et al, Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene. 1996; 179: 133–40. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gentschev I, Glaser I, Goebel W, et al, Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infect Immun. 1998; 66: 2060–4. [PUBMED], [INFOTRIEVE]
- Hess J, Grode L, Gentschev I, et al, Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination. Microbes Infect. 2000; 2: 1799–806. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Shata M T, Stevceva L, Agwale S, et al, Recent advances with recombinant bacterial vaccine vectors. Mol Med Today. 2000; 6: 66–71. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Dietrich G, Bubert A, Gentschev I, et al, Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol. 1998; 16: 181–5. [PUBMED], [INFOTRIEVE]
- Gentschev I, Dietrich G, Spreng S, et al, Delivery of protein antigens and DNA by attenuated intracellular bacteria. Int J Med Microbiol. 2002; 291: 577–82. [PUBMED], [INFOTRIEVE]
- Shiau A L, Chen Y L, Liao C Y, et al, Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis. Vaccine. 2001; 19: 3947–56. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Darji A, zur Lage S, Garbe A I, et al, Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol. 2000; 27: 341–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Brunham R C, Zhang D.. Transgene as vaccine for chlamydia. Am Heart J. 1999; 138: S519–22. [PUBMED], [INFOTRIEVE]
- Al-Mariri A, Tibor A, Lestrate P, et al, Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Infect Immun. 2002; 70: 1915–23. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Loser P, Huser A, Hillgenberg M, et al, Advances in the development of non-human viral DNA-vectors for gene delivery. Curr Gene Ther. 2002; 2: 161–71. [PUBMED], [INFOTRIEVE]
- Chaplin P J, De, Rose R, Boyle J S, et al, Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun. 1999; 67: 6434–8. [PUBMED], [INFOTRIEVE]
- Manoj S, Griebel P J, Babiuk L A, et al, Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep. J Immunol. 2003; 170: 989–96. [PUBMED], [INFOTRIEVE]
- Drew D R, Boyle J S, Lew A M, et al, The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. Vaccine. 2001; 19: 4417–28. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Dean H J, Terhune S S, Shieh M T, et al, Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity. Virology. 1994; 199: 67–80. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Smahel M, Sima P, Ludvikova V, et al, Modified HPV16 E7 genes as DNA vaccine against E7-containing oncogenic cells. Virology. 2001; 281: 231–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Prodinger W M.. Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping. Immunol Res. 1999; 20: 187–94. [PUBMED], [INFOTRIEVE]
- Nielsen C H, Fischer E M, Leslie R G.. The role of complement in the acquired immune response. Immunology. 2000; 100: 4–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Suradhat S, Braun R P, Lewis P J, et al, Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. Vet Immunol Immunopathol. 2001; 83: 79–92. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Green T D, Newton B R, Rota P A, et al, C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine. 2001; 20: 242–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ross T M, Xu Y, Green T D, et al, Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res Hum Retroviruses. 2001; 17: 829–35. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Fanslow W C, Srinivasan S, Paxton R, et al, Structural characteristics of CD40 ligand that determine biological function. Semin Immunol. 1994; 6: 267–78. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Maxwell J R, Campbell J D, Kim C H, et al, CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol. 1999; 162: 2024–34. [PUBMED], [INFOTRIEVE]
- Frleta D, Demian D, Wade W F.. Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo. Int Immunopharmacol. 2001; 1: 265–75. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Koch N, van, Driel I R, Gleeson P A.. Hijacking a chaperone: manipulation of the MHC class II presentation pathway. Immunol Today. 2000; 21: 546–50. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rodriguez F, Harkins S, Redwine J M, et al, CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J Virol. 2001; 75: 10421–30. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Leifert J A, Lindencrona J A, Charo J, et al, Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine. Hum Gene Ther. 2001; 12: 1881–92. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Fu T M, Guan L, Friedman A, et al, Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens. Vaccine. 1998; 16: 1711–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Leachman S A, Shylankevich M, Slade M D, et al, Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines. J Virol. 2002; 76: 7616–24. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Delogu G, Howard A, Collins F M, et al, DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. Infect Immun. 2000; 68: 3097–102. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Vidalin O, Tanaka E, Spengler U, et al, Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination. DNA Cell Biol. 1999; 18: 611–21. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Phelan A, Elliott G, O'Hare P.. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol. 1998; 16: 440–3. [PUBMED], [INFOTRIEVE]
- Dilber M S, Phelan A, Aints A, et al, Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 1999; 6: 12–21. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Elliott G, O'Hare P.. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 1997; 88: 223–33. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Harms J S, Ren X, Oliveira S C, et al, Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J Virol. 2000; 74: 3301–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hung C F, He L, Juang J, et al, Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. J Virol. 2002; 76: 2676–82. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hung C F, Cheng W F, Chai C Y, et al, Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J Immunol. 2001; 166: 5733–40. [PUBMED], [INFOTRIEVE]
- Michel N, Osen W, Gissmann L, et al, Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology. 2002; 294: 47–59. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Oliveira S C, Harms J S, Afonso R R, et al, A genetic immunization adjuvant system based on BVP22-antigen fusion. Hum Gene Ther. 2001; 12: 1353–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Aints A, Dilber M S, Smith C I.. Intercellular spread of GFP-VP22. J Gene Med. 1999; 1: 275–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cheng W F, Hung C H, Chai C Y, et al, Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen. J Virol. 2001; 75: 2368–76. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Zinkernagel R M, Hengartner H.. Regulation of the immune response by antigen. Science. 2001; 293: 251–3. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Yu Z, Karem K L, Kanangat S, et al, Protection by minigenes: a novel approach of DNA vaccines. Vaccine. 1998; 16: 1660–7. [PUBMED], [INFOTRIEVE]
- Kedl R M, Rees W A, Hildeman D A, et al, T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med. 2000; 192: 1105–13. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Restifo N P, Bacik I, Irvine K R, et al, Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol. 1995; 154: 4414–22. [PUBMED], [INFOTRIEVE]
- Scheerlinck J Y.. Genetic adjuvants for DNA vaccines. Vaccine. 2001; 19: 2647–56. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kusakabe K, Xin K Q, Katoh H, et al, The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol. 2000; 164: 3102–11. [PUBMED], [INFOTRIEVE]
- Barouch D H, Santra S, Steenbeke T D, et al, Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol. 1998; 161: 1875–82. [PUBMED], [INFOTRIEVE]
- Pulendran B, Smith J L, Caspary G, et al, Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA. 1999; 96: 1036–41. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lim Y S, Kang B Y, Kim E J, et al, Vaccination with an ovalbumin/interleukin-4 fusion DNA efficiently induces Th2 cell-mediated immune responses in an ovalbumin-specific manner. Arch Pharm Res. 1998; 21: 537–42. [PUBMED], [INFOTRIEVE]
- Inoue T, Inoue Y, Nakamura T, et al, The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis. Jpn J Ophthalmol. 2002; 46: 370–76. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Landolfi N F.. A chimeric IL-2/Ig molecule possesses the functional activity of both proteins. J Immunol. 1991; 146: 915–9. [PUBMED], [INFOTRIEVE]
- Kim J J, Ayyavoo V, Bagarazzi M L, et al, In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 1997; 158: 816–26. [PUBMED], [INFOTRIEVE]
- Kim J J, Nottingham L K, Tsai A, et al, Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants. J Med Primatol. 1999; 28: 214–23. [PUBMED], [INFOTRIEVE]
- Xiang Z, Ertl H C.. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 1995; 2: 129–35. [PUBMED], [INFOTRIEVE]
- Xiang Z Q, He Z, Wang Y, et al, The effect of interferon-gamma on genetic immunization. Vaccine. 1997; 15: 896–8. [PUBMED], [INFOTRIEVE]
- Tsuji T, Fukushima J, Hamajima K, et al, HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology. 1997; 90: 1–6. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Flo J, Tisminetzky S, Baralle F.. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules. Immunology. 2000; 100: 259–67
- Lee S W, Youn J W, Seong B L, et al, IL-6 induces long-term protective immunity against a lethal challenge of influenza virus. Vaccine. 1999; 17: 490–6. [PUBMED], [INFOTRIEVE]
- Okada E, Sasaki S, Ishii N, et al, Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol. 1997; 159: 3638–47. [PUBMED], [INFOTRIEVE]
- Chow Y H, Chiang B L, Lee Y L, et al, Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol. 1998; 160: 1320–9. [PUBMED], [INFOTRIEVE]
- Kim J J, Trivedi N N, Nottingham L K, et al, Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol. 1998; 28: 1089–103. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Arrington J, Braun R P, Dong L, et al, Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. J Virol. 2002; 76: 4536–46. [CROSSREF], [PUBMED], [INFOTRIEVE]
- McShane H.. Prime-boost immunization strategies for infectious diseases. Curr Opin Mol Ther. 2002; 4: 23–7. [PUBMED], [INFOTRIEVE]
- Schneider J, Langermans J A, Gilbert S C, et al, A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine. 2001; 19: 4595–602. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Busch D H, Pamer E G.. T cell affinity maturation by selective expansion during infection. J Exp Med. 1999; 189: 701–10. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rees W, Bender J, Teague T K, et al, An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci USA. 1999; 96: 9781–6. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bramson J L, Wan Y H.. The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen. Expert Opin Biol Ther. 2002; 2: 75–85. [PUBMED], [INFOTRIEVE]
- Ramshaw I A, Ramsay A J.. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today. 2000; 21: 163–5. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Palmowski M J, Choi E M, Hermans I F, et al, Competition between CTL narrows the immune response induced by prime-boost vaccination protocols. J Immunol. 2002; 168: 4391–8. [PUBMED], [INFOTRIEVE]
- Letvin N L, Montefiori D C, Yasutomi Y, et al, Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA. 1997; 94: 9378–83. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Yuan R, Primakoff P, Myles D G.. A role for the disintegrin domain of cyritestin, a sperm surface protein belonging to the ADAM family, in mouse sperm-egg plasma membrane adhesion and fusion. J Cell Biol. 1997; 137: 105–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Jansen S, Ekhlasi-Hundrieser M, Topfer-Petersen E.. Sperm adhesion molecules: structure and function. Cells Tissues Organs. 2001; 168: 82–92. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Barry M A, Lai W C, Johnston S A.. Protection against mycoplasma infection using expression-library immunization. Nature. 1995; 377: 632–5. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cooke H.. Mammalian artificial chromosomes as vectors: progress and prospects. Cloning Stem Cells. 2001; 3: 243–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Saffery R, Choo K H.. Strategies for engineering human chromosomes with therapeutic potential. J Gene Med. 2002; 4: 5–13. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Dufresne I, Desormeaux A, Bestman-Smith J, et al, Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments. Biochim Biophys Acta. 1999; 1421: 284–94. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Estrada A, McDermott M R, Underdown B J, et al, Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies. Vaccine. 1995; 13: 901–7. [PUBMED], [INFOTRIEVE]
- Boyle J S, Brady J L, Lew A M.. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature. 1998; 392: 408–11. [PUBMED], [INFOTRIEVE]
- You Z, Huang X, Hester J, et al, Targeting dendritic cells to enhance DNA vaccine potency. Cancer Res. 2001; 61: 3704–11. [PUBMED], [INFOTRIEVE]
- Abbas A K, Lichtman A H, S. P J.. Antigen receptors and accessory molecules of T lymphocytes, In:. Schmitt W, Hacker H N, Ehlers J. Cellular and Moleucular Immunology, 4th edition, pp. 102–21, Saunders Company, Philadelphia 2000
- Epel M, Ellenhorn J D, Diamond D J, et al, A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells. Cancer Immunol Immunother. 2002; 51: 565–73. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lunde E, Rasmussen I B, Eidem J K, et al, ‘Troy-bodies’: antibodies as vector proteins for T cell epitopes. Biomol Eng. 2001; 18: 109–16. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gilbert S C, Schneider J, Hannan C M, et al, Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine. 2002; 20: 1039–45. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rothel J S, Boyle D B, Both G W, et al, Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol. 1997; 19: 221–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hammond J M, Jansen E S, Morrissy C J, et al, A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever. Vet Microbiol. 2001; 80: 101–19. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Shiver J W, Fu T M, Chen L, et al, Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature. 2002; 415: 331–5. [CROSSREF], [PUBMED], [INFOTRIEVE]
- McShane H, Brookes R, Gilbert S C, et al, Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun. 2001; 69: 681–6. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schneider J, Gilbert S C, Blanchard T J, et al, Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med. 1998; 4: 397–402. [PUBMED], [INFOTRIEVE]
- Leong K H, Ramsay A J, Boyle D B, et al, Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol. 1994; 68: 8125–30. [PUBMED], [INFOTRIEVE]
- Loehr B I, Pontarollo R, Rankin R, et al, Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. J Gen Virol. 2001; 82: 3035–43. [PUBMED], [INFOTRIEVE]
- Webster D E, Cooney M L, Huang Z, et al, Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine. J Virol. 2002; 76: 7910–2. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Moraes M P, Mayr G A, Mason P W, et al, Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine. 2002; 20: 1631–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hammond J M, Jansen E S, Morrissy C J, et al, Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus. Vaccine. 2001; 19: 3752–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bruna-Romero O, Gonzalez-Aseguinolaza G, Hafalla J C, et al, Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc Natl Acad Sci USA. 2001; 98: 11491–6. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lubeck M D, Natuk R, Myagkikh M, et al, Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat Med. 1997; 3: 651–8. [PUBMED], [INFOTRIEVE]
- Yoshida T, Okuda K, Xin K Q, et al, Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols. Clin Exp Immunol. 2001; 124: 445–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Meseda C A, Elkins K L, Merchlinsky M J, et al, Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone. J Infect Dis. 2002; 186: 1065–73. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kaneko H, Bednarek I, Wierzbicki A, et al, Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology. 2000; 267: 8–16. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Wild T F, Bernard A, Spehner D, et al, Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J Gen Virol. 1992; 73: 359–67. [PUBMED], [INFOTRIEVE]
- Li S, Rodrigues M, Rodriguez D, et al, Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA. 1993; 90: 5214–8. [PUBMED], [INFOTRIEVE]
- Earl P L, Wyatt L S, Montefiori D C, et al, Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Virology. 2002; 294: 270–81. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gilbert S C, Schneider J, Plebanski M, et al, Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; Comparisons and combinations. Biol Chem. 1999; 380: 299–303. [PUBMED], [INFOTRIEVE]
- Oliveira-Ferreira J, Miyahira Y, Layton G T, et al, Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus. Vaccine. 2000; 18: 1863–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nilsson C, Makitalo B, Berglund P, et al, Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara. Vaccine. 2001; 19: 3526–36. [CROSSREF], [PUBMED], [INFOTRIEVE]